These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
449 related articles for article (PubMed ID: 36910014)
21. To explore the prognostic characteristics of colon cancer based on tertiary lymphoid structure-related genes and reveal the characteristics of tumor microenvironment and drug prediction. Wang Z; Niu D Sci Rep; 2024 Jun; 14(1):13555. PubMed ID: 38867070 [TBL] [Abstract][Full Text] [Related]
22. Prognostic value of fatty acid metabolism-related genes in colorectal cancer and their potential implications for immunotherapy. Huang X; Sun Y; Song J; Huang Y; Shi H; Qian A; Cao Y; Zhou Y; Wang Q Front Immunol; 2023; 14():1301452. PubMed ID: 38045683 [TBL] [Abstract][Full Text] [Related]
23. Identification of a Four-Gene Metabolic Signature to Evaluate the Prognosis of Colon Adenocarcinoma Patients. Zheng Y; Wu R; Wang X; Yin C Front Public Health; 2022; 10():860381. PubMed ID: 35462848 [TBL] [Abstract][Full Text] [Related]
24. Development of a 5-mRNAsi-related gene signature to predict the prognosis of colon adenocarcinoma. Huang H; Lu L; Li Y; Chen X; Li M; Yang M; Huang X PeerJ; 2023; 11():e16477. PubMed ID: 38025763 [TBL] [Abstract][Full Text] [Related]
25. Identification of Ferroptosis-Related Genes Signature Predicting the Efficiency of Invasion and Metastasis Ability in Colon Adenocarcinoma. Shi C; Xie Y; Li X; Li G; Liu W; Pei W; Liu J; Yu X; Liu T Front Cell Dev Biol; 2021; 9():815104. PubMed ID: 35155451 [No Abstract] [Full Text] [Related]
26. A potential prognostic prediction model of colon adenocarcinoma with recurrence based on prognostic lncRNA signatures. Jin L; Li C; Liu T; Wang L Hum Genomics; 2020 Jun; 14(1):24. PubMed ID: 32522293 [TBL] [Abstract][Full Text] [Related]
27. Comprehensive analysis of the prognosis, tumor microenvironment, and immunotherapy response of SDHs in colon adenocarcinoma. Nan H; Guo P; Fan J; Zeng W; Hu C; Zheng C; Pan B; Cao Y; Ge Y; Xue X; Li W; Lin K Front Immunol; 2023; 14():1093974. PubMed ID: 36949947 [TBL] [Abstract][Full Text] [Related]
28. CTHRC1 is a prognosis-related biomarker correlated with immune infiltrates in colon adenocarcinoma. Meng C; Zhang Y; Jiang D; Wang J World J Surg Oncol; 2022 Mar; 20(1):89. PubMed ID: 35307012 [TBL] [Abstract][Full Text] [Related]
29. Identification of DLL3-related genes affecting the prognosis of patients with colon adenocarcinoma. Xiang J; Gong W; Liu J; Zhang H; Li M; Wang R; Lv Y; Sun P Front Genet; 2023; 14():1098190. PubMed ID: 37274780 [No Abstract] [Full Text] [Related]
30. Based on cuproptosis-related lncRNAs, a novel prognostic signature for colon adenocarcinoma prognosis, immunotherapy, and chemotherapy response. Li C; Zhang K; Gong Y; Wu Q; Zhang Y; Dong Y; Li D; Wang Z Front Pharmacol; 2023; 14():1200054. PubMed ID: 37377924 [No Abstract] [Full Text] [Related]
31. Investigating gene signatures associated with immunity in colon adenocarcinoma to predict the immunotherapy effectiveness using NFM and WGCNA algorithms. Liang W; Yang X; Li X; Wang P; Zhu Z; Liu S; Xu D; Zhi X; Xue J Aging (Albany NY); 2024 May; 16(9):7596-7621. PubMed ID: 38742936 [TBL] [Abstract][Full Text] [Related]
32. A Prognostic Model for Colon Adenocarcinoma Patients Based on Ten Amino Acid Metabolism Related Genes. Ren Y; He S; Feng S; Yang W Front Public Health; 2022; 10():916364. PubMed ID: 35712285 [TBL] [Abstract][Full Text] [Related]
33. Discovery and Validation of an Epithelial-Mesenchymal Transition-Based Signature in Gastric Cancer by Genomics and Prognosis Analysis. Xu H; Wan H; Zhu M; Feng L; Zhang H; Su F Biomed Res Int; 2021; 2021():9026918. PubMed ID: 34746312 [TBL] [Abstract][Full Text] [Related]
34. Comprehensive analysis of the immune implication of FABP4 in colon adenocarcinoma. Wu D; Xiang L; Peng L; Gu H; Tang Y; Luo H; Liu H; Wang Y PLoS One; 2022; 17(10):e0276430. PubMed ID: 36264920 [TBL] [Abstract][Full Text] [Related]
35. Multi-omics analysis reveals focal adhesion characteristic associated tumor immune microenvironment in colon adenocarcinoma. Xu X; Wang J Front Genet; 2023; 14():1088091. PubMed ID: 36950136 [TBL] [Abstract][Full Text] [Related]
36. Exploration of an Prognostic Signature Related to Endoplasmic Reticulum Stress in Colorectal Adenocarcinoma and Their Response Targeting Immunotherapy. Xu Y; Xie YM; Sun WS; Zi R; Lu HQ; Xiao L; Gong KM; Guo SK Technol Cancer Res Treat; 2023; 22():15330338231212073. PubMed ID: 37920989 [No Abstract] [Full Text] [Related]
37. Exploring and validating the necroptotic gene regulation and related lncRNA mechanisms in colon adenocarcinoma based on multi-dimensional data. Wang W; Liu Y; Wang Z; Tan X; Jian X; Zhang Z Sci Rep; 2024 Sep; 14(1):22251. PubMed ID: 39333335 [TBL] [Abstract][Full Text] [Related]
38. Developing a prognosis and chemotherapy evaluating model for colon adenocarcinoma based on mitotic catastrophe-related genes. Liu Y; Zhao Y; Zhang S; Rong S; He S; Hua L; Wang X; Chen H Sci Rep; 2024 Jan; 14(1):1655. PubMed ID: 38238555 [TBL] [Abstract][Full Text] [Related]
39. Construction and validation of a cuproptosis-related lncRNA signature as a novel and robust prognostic model for colon adenocarcinoma. Xu M; Mu J; Wang J; Zhou Q; Wang J Front Oncol; 2022; 12():961213. PubMed ID: 35965536 [TBL] [Abstract][Full Text] [Related]
40. Development and Validation of a Prognostic Model based on 11 E3-related Genes for Colon Cancer Patients. JIang W; Dong J; Zhang W; Huang Z; Guo T; Zhang K; Jiang X; Du T Curr Pharm Des; 2024; 30(12):935-951. PubMed ID: 38898815 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]